Intravitreal ranibizumab as a primary or a combined treatment for severe retinopathy of prematurity
Odalis Arámbulo,1 Gabriel Dib,1 Juan Iturralde,1 Fahir Duran,1 Miguel Brito,1 João B Fortes Filho2 1Department of Ophthalmology, University Hospital of Maracaibo, Maracaibo, Venezuela; 2Department of Ophthalmology, Hospital de Clínicas de Porto Alegre, Federal Unive...
Guardado en:
Autores principales: | Arámbulo O, Dib G, Iturralde J, Duran F, Brito M, Fortes Filho JB |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2015
|
Materias: | |
Acceso en línea: | https://doaj.org/article/c2f3b0548d814030924fff345b1de520 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Prevalence of retinopathy of prematurity in Latin America
por: Carrion JZ, et al.
Publicado: (2011) -
Multiple pregnancies and its relationship with the development of retinopathy of prematurity (ROP)
por: Fiorot CA, et al.
Publicado: (2011) -
Refractive outcome of prethreshold retinopathy of prematurity treated by diode laser: follow-up at 5 years
por: Nguyen PH, et al.
Publicado: (2015) -
Conversion to aflibercept for diabetic macular edema unresponsive to ranibizumab or bevacizumab
por: Lim LS, et al.
Publicado: (2015) -
Intravitreal injection of ranibizumab using a pro re nata regimen for age-related macular degeneration and vision-related quality of life
por: Inoue M, et al.
Publicado: (2014)